Institute of Emerging Health Professions - Cannabinoid Pharmacology is organized by Thomas Jefferson University (TJU).  The graduate certificate in Cannabinoid Pharmacology is outlined to prepare learners with the mechanisms of drug action and highlights of pharmacokinetics as it correlates to cannabis. Continue Education Credits: Applied CNS Pharmacology and Toxicology (optional)--- 3 Hours Cannabinoid Pharmacology & Toxicology --- 3 Hours Cannabinoid Pharmacokinetics --- 3 Hours Cultural History, Regulation, and Policy of Cannabis --- 3 Hours OR Cannabinoid Research Design --- 3 Hours Overview: The legal cannabis industry is expected to be one of the fastest-growing sectors of the US economy over the next decade. There are, however, some educational assemblies that present scientists, researchers, and clinicians to join this burgeoning field. This is the very first-of-its-kind graduate certificate in Cannabinoid Pharmacology, which is now accessible for interested students with a proper background in chemistry, biochemistry, pharmacology, toxicology, or physiology. Objectives: At the conclusion of the online CME Certification in Cannabinoid Pharmacology program, students must be able to, • Access drug action mechanisms(pharmacodynamics) • Define central nervous system neurotransmission • Explain features of pharmacokinetics (administration, distribution, metabolism, excretion) • Describe the pharmacology of stimulants, depressants, cannabinoids, hallucinogens, antipsychotics • Illustrate the prevailing awareness of drug abuse complications and addiction • Explain the historical use of cannabis • Examine the changes in public opinion about cannabis use • Learn past and prevailing US government cannabis-related regulations and regulatory topics Fall 2020 Start Date:  September 1, 2020 Program Length: 1-2 years FALL 2018: • Applied CNS Pharmacology and Toxicology (prerequisite) Course Number: CPY 500 Credit Hours: 3 • Cultural History, Regulation, and Policy of Cannabis Course Number: CPY 510 Credit Hours: 3 SPRING 2019: • Cannabinoid Pharmacology & Toxicology Course Number: CPY 501 Credit Hours: 3 SUMMER 2019: • Cannabinoid Pharmacokinetics Course Number: CPY 506 Credit Hours: 3

Connecting with Patients for Tobacco Free Living - Online is organized by Mayo Clinic. Course opens: 07/20/2015 Course expires: 07/20/2021 Target Audience: ​This program is designed for physicians and other healthcare professionals experienced in working with tobacco dependent patients, and who are interested in incorporating more effective treatment into their practice and/ or developing more comprehensive services to meet the needs of highly tobacco dependent patients. Physicians, tobacco treatment specialists, nurse practitioners, physician assistants, dentists, pharmacists, psychologists, chemical dependency counselors, respiratory therapists, nurses, dental hygienists, social workers, and other allied health professionals may find the conference beneficial in working with this challenging population of patients. Available Credit: • 3.50 AMA PRA Category 1 Credit™ • 3.50 Attendance Learning Objectives: Upon the conclusion of this program, participants should be able to: • Describe up to date research on pharmacotherapy and behavioral counseling for treating tobacco dependence. • Apply current research on tobacco treatment to participant's clinical practice. Attendance at this Mayo course does not indicate nor guarantee competence or proficiency in the performance of any procedures which may be discussed or taught in this course. Additional details will be posted as soon as they are available.

Intravenous N-Acetylcysteine for Acetaminophen Toxicity is organized by American Association of Critical - Care Nurses (AACN) and will be held during Dec 01, 2017 - Dec 01, 2020. Accreditation : The American Association of Critical-Care Nurses (AACN) is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s (ANCC's) Commission on Accreditation, ANCC Provider Number 0012 (60 min contact hour). AACN has been approved as a provider of continuing education in nursing by the California State Board of Nursing, California Provider number CEP01036 for 1 contact hours Activity Summary : The clinical manifestations of acetaminophen toxicity can present along with a spectrum ranging from asymptomatic and nonspecific symptoms to fulminant hepatic failure and possibly death. Diagnosis of an acetaminophen overdose depends on signs and symptoms, patient history, time of ingestion, quantity consumed, and various laboratory values. This article describes acetaminophen toxicity, treatment regimens using N-acetylcysteine, and monitoring parameters. Objectives : • Describe the clinical presentation and appropriate use of the Modified Rumack-Matthew nomogram for acetaminophen toxicity. • Develop a treatment regimen and monitoring plan using N-acetylcysteine for acetaminophen toxicity. • Identify special patient populations that require intravenous N-acetylcysteine dosing adjustments. Additional details will be posted as soon as they are available.

Letting the Patient Decide: A Case Report of Sedative Self-Administration During Mechanical Ventilation is organized by American Association of Critical - Care Nurses (AACN) and will be held during Jan 31, 2018 - Feb 01, 2021. Accreditation : The American Association of Critical-Care Nurses (AACN) is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s (ANCC's) Commission on Accreditation, ANCC Provider Number 0012 (60 min contact hour). AACN has been approved as a provider of continuing education in nursing by the California State Board of Nursing, California Provider number CEP01036 for 1 contact hours. Activity Summary : This article depicts a case study of one patient who used self-administered dexmedetomidine which was very well tolerated, provided relaxation and comfort, which resulted in positive remarks from the patient. The clinical course of this patient suggests that dexmedetomidine helped manage individually perceived anxiety in a way that allowed the patient to remain alert, realizing the goal of early extubation and postsurgical recovery. Objectives : • Describe the current clinical practice guidelines recommendations for the administration of sedation during critical illness. • Explain why dexmedetomidine is the ideal drug for the self-administration of sedation. • Identify two physiologic parameters that are important to monitor during the self-administration of dexmedetomidine. Additional details will be posted as soon as they are available.

Management of Nosocomial Pneumonia is organized by the American Association of Critical-Care Nurses (AACN). This online Cm conference is held from Mar 01, 2018 - Mar 01, 2021. Accreditation : The American Association of Critical-Care Nurses (AACN) is an authorized provider of continuing nursing education by the American Nurses Credentialing Center’s (ANCC's) Commission on Accreditation, ANCC Provider Number 0012 (60 min contact hour). AACN has been recognized as an accreditated provider of continuing education in nursing by the California State Board of Nursing, California Provider Number CEP01036 for 1 contact hours. Activity Summary : This article reviews modern recommendations for the management of nosocomial pneumonia, based on the 2016 clinical practice guidelines produced by the Infectious Diseases Society of America (IDSA) and the American Thoracic Society (ATS). Definitions and relevant therapy are presented, as there is major differential treatment from the original 2005 guidelines. These changes involve the replacement of the term healthcare-associated pneumonia (HCAP), the use of antibiograms, the retreat of aminoglycoside mono-therapy and the use of adjunctive gasped antibiotic therapy and a recommended treatment duration of 7 days for most patients. Objectives : • Review major changes in the 2016 ATS/IDSA nosocomial pneumonia guidelines. • Enter major risk factors & microbiological causes of pneumonia. • Consult proper antibiotic therapy & monitoring parameters for the management of nosocomial pneumonia. Additional details will be posted as soon as they are available.

Residual Neuromuscular Blockade in the Critical Care Setting is organized by American Association of Critical - Care Nurses (AACN) and will be held during Mar 01, 2018 - Mar 01, 2021. Accreditation : The American Association of Critical-Care Nurses (AACN) is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s (ANCC's) Commission on Accreditation, ANCC Provider Number 0012 (60 min contact hour). AACN has been approved as a provider of continuing education in nursing by the California State Board of Nursing, California Provider number CEP01036 for 1.2 contact hours (50 min contact hour). Activity Summary : The article includes a review of the current uses for the neuromuscular blockade, pathophysiology of the neuromuscular junction, pharmacologic characteristics of neuromuscular blocking agents (including drug-drug interactions), monitoring modalities, and effectiveness of reversal agents. Treatment recommendations pertinent to residual neuromuscular blockade are outlined. Objectives : • Facilitate the safe recovery of patients undergoing general anesthesia. • Identify early signs of deterioration, complications, and patient risk factors associated with residual paralysis. • Evaluate treatment interventions for those patients with evidence of residual neuromuscular blockade. Additional details will be posted as soon as they are available.

Diabetes-Pharmacologic Management Update is organized by the American Nurses Association (ANA) and will be held during Apr 04, 2018 - Jan 03, 2021. This Online CME Conference has been assigned for a maximum of 1.53 Contact Hours credits. Course Description : The number of people with diabetes is rising exponentially according to data from the National Center for Health Statistics. Diabetes continues to take a severe toll and is the leading cause of microvascular complications that lead to blindness, amputation, and kidney failure. Blocking these complications requires aggressive management. Since the advent of insulin, several other medications and technologies have been produced to help with this management, along with the home and continuous glucose monitoring, multiple basal insulins, and new classes of oral and injectable medications. Most people with diabetes now take multiple medications to manage glucose levels and comorbidities. This online article presents an update on diabetes medications, converging on concentrated insulin and noninsulin. Learning Outcomes are : • Differentiate types of concentrated insulin. • Distinguish three categories of noninsulin medications used to treat patients with diabetes. • Evaluate nursing actions for patients with diabetes who are obtaining concentrated insulin or noninsulin medications. Additional details will be posted as soon as they are available.

Pharmacologic Interventions to Prevent Cognitive Decline, Mild Cognitive Impairment (MCI), and Clinical Alzheimer-Type Dementia: A Systematic Review is organized by American College of Physicians (ACP) and will be held during Apr 23, 2018 - Dec 19, 2020. This CME Conference has been approved for a maximum of 1.0 AMA PRA Category 1 Credits and MOC Points. Additional details will be posted as soon as they are available.

Hemoglobin A1c Targets for Glycemic Control With Pharmacologic Therapy for Nonpregnant Adults With Type 2 Diabetes Mellitus: A Guidance Statement Update From the American College of Physicians is organized by American College of Physicians (ACP) and will be held during Apr 28, 2018 - Mar 06, 2021. This CME Conference has been approved for a maximum of 1.0 AMA PRA Category 1 Credits and MOC Points. Additional details will be posted as soon as they are available.

Infectious Disease/Antibiotic Stewardship: New Antibiotics, Complicated Infections and MRSA is organized by University Learning Systems (ULS). Course Expiration Date: 04/01/2022 Accreditation: This program in its entirety provides 5 hours (0.5 CEU) of ACPE CPE home study credit, AMA Category 2 CME, and CNE pharmacology credit. Course Objectives: At the conclusion of this session, the participant will be able to: New Antimicrobial Update: Has help truly arrived? 1. Review various new antimicrobials that have been FDA-approved. 2. Discuss pros and cons of these agents. 3. Evaluate these agents critically for use in clinical practice. 4. Compare the possible role of these agents through cases. Difficult Cases in Infectious Diseases: Are you up for the challenge? 5. Differentiate pharmacotherapy options for complicated infections. 6. Develop a plan to manage these infections. 7. Propose treatment options for resistant Gram-negative pathogens . Update in the Treatment of MRSA Acute Bacterial Skin/Skin Structure Infections (ABSSSI) 8. Discuss the epidemiology of ABSSSI including MRSA. 9. List agents commonly used in the management of ABSSSI. 10. Summarize guidelines for management of ABSSSI. 11. Select an appropriate treatment based on patient ABSSSI presentation. Additional details will be posted as soon as information is available.